Menopausal genuine stress urinary incontinence treated with conjugated estrogens plus progestogens

Discipline of Gynecology, Escola Paulista de Medicina, São Paulo Hospital, Brazil.
International Journal of Gynecology & Obstetrics (Impact Factor: 1.54). 05/1995; 49(2):165-9. DOI: 10.1016/0020-7292(95)02358-J
Source: PubMed


The aim of the study was to investigate clinically and urodynamically the effects of hormonal replacement in the treatment of genuine stress urinary incontinence in postmenopausal females.
Clinical and urodynamic variables of 30 postmenopausal women with genuine stress urinary incontinence were evaluated after 3 months' treatment with conjugated estrogens plus progestogens. Urodynamic evaluations were performed in all patients before and after treatment.
Forty-six percent of the patients treated medically were judged to be cured and 43% were judged to be markedly improved. Maximum urethral closure pressure, maximum cystometric capacity and mean flow were significantly increased. Residual urine and diurnal and nocturnal voluntary micturition were markedly decreased (P < 0.05).
We conclude that hormone replacement in the form of conjugated estrogens plus progestogens results in the clinical and urodynamic improvement of genuine stress urinary incontinence in postmenopausal women.

8 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Slow and fast twitch fibres were stereologically analysed in the morphologically defined and most strongly developed ventral and ventrolateral region of the external urethral sphincter (M. urethralis) using five sexually intact anestrous and five ovariectomized nulliparous beagles. The estimated mean total cross-sectional area of the investigated part of the muscle consisted of 4.2 mm2 (15.1%) type I fibre, 10.0 mm2 (32.1%) type II fibre, and 16.3 mm2 (52.8%) connective tissue in the control group. The corresponding absolute mean value of type I fibres (3.7 mm2/13.5%) was statistically lower in ovariectomized animals. No significant difference between groups was observed in the relative number of transverse profiles of type I and II fibres; type I fibres comprised 23.8% and type II 76.2% of all muscle fibres in the sexually intact group, but 21.8% and 78.2% in the ovariectomy group, respectively. The ovariectomized dogs exhibited a statistically significant lower type I and II fibre number and a concomitant slightly larger mean single profile area (diameter) of fibre type II compared with the control animals. The significantly reduced number and decreased total cross-sectional area of the fatigue-resistant type I fibres in ovariectomized dogs suggest a predominant weakening of the fibre type I portion of the M. urethralis as consequence of ovariectomy. The effect could be mediated by sex hormonal factors and may contribute to the development of postspaying urinary incontinence in female dogs.
    Urological Research 02/1998; 26(6):417-22. DOI:10.1007/s002400050079 · 1.39 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Urinary complaints such as urinary incontinence, urinary tract infections, nocturia, and urinary urgency are common in women. The prevalence of these urinary conditions increases with age. Factors which are related to a rise in urinary complaints include age-related changes in bladder and urethral function, comorbid medical conditions, medications, and changes in the hormonal milieu. In fact, some studies have shown a distinct rise in the prevalence of urinary incontinence after menopause [30] and [52]; however, others [24] and [67] have not found menopause to be an independent risk factor for urinary incontinence. It is tempting to place blame on the hormonal changes associated with menopause when considering etiologic factors for urinary complaints. Several researchers have shown that the urethra and bladder contain a rich supply of estrogen receptors in women, which presumably would affect urogenital function. Whether research confirms this hypothesis and whether estrogen therapy can be used to treat these common urinary complaints are the main subjects of this article. In addition, we briefly review the evaluation of urinary incontinence, nocturia, and urgency that is required before beginning therapy and other nonsurgical modalities for treating incontinence. The use of estrogen replacement therapy for the prevention of urinary tract infection is also discussed.
    The Journal of Urology 03/1998; 159(2-26):347-360. DOI:10.1016/S0889-8529(05)70251-6 · 4.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Urinary incontinence is usually classified into four types: stress, urge, reflex and overflow incontinence. The first three types of incontinence are due to urine storage dysfunction and the latter is due to urine emptying dysfunction. To improve urine storage dysfunction treatment should be aimed at decreasing detrusor overactivity, increasing bladder capacity and/or increasing outlet resistance, whereas to improve emptying dysfunction, increasing detrusor contractility and/or decreasing outlet resistance are required. This review summarizes the various drugs currently in clinical use and new drugs under investigation.
    Drugs of today (Barcelona, Spain: 1998) 03/1998; 34(2):125-38. DOI:10.1358/dot.1998.34.2.485185 · 1.20 Impact Factor
Show more